Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
Academic Medical Center · Ziekenhuis Bethesda · +2 more institutions
Indexed incrossrefpubmed
Abstract
Objectives
To study the effects of metformin on the incidence of vitamin B-12 deficiency (220 pmol/l).
Conclusions
Long term treatment with metformin increases the risk of vitamin B-12 deficiency, which results in raised homocysteine concentrations. Vitamin B-12 deficiency is preventable; therefore, our findings suggest that regular measurement of vitamin B-12 concentrations during long term metformin treatment should be strongly considered. Trial registration Clinicaltrials.gov NCT00375388.
Citation impact
680
total citations
- FWCI
- 28.93
- Percentile
- 100%
- References
- 35
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Metformin
- Placebo
- Internal medicine
- Type 2 diabetes
- Homocysteine
- Confidence interval
- Diabetes mellitus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.